Rentokil Revenue Up 4.3%, Shares Down 1.3%

Rentokil Initial reported total Q1 revenue of $1.68 bn, a 4.3% increase year‑on‑year, beating analyst expectations.
North America revenue rose 4.5% to $995 m with 2.8% organic growth, while International revenue grew 4.1% but missed 3.6% organic forecast.
The company acquired nine businesses totaling $19 m annualized revenue and kept its full‑year outlook unchanged, matching market expectations.
Despite the earnings beat, Rentokil shares fell about 1.3% as international segments lagged and a 60‑bp headwind hit Pacific and MENAT regions.